Version 2.3 of the Budget Impact Model was published on 13th April 2026 and replaces version 2.2. The new version is available here.
The NCPE-Budget-Impact-Guideline has also been updated. The aim of this guideline is to provide guidance on the conduct of a drug budget impact analysis (BIA).
For those companies who have already started to prepare a Budget Impact Model, the previous version of the template (Version 2.2) will be acceptable until the 13th July 2026.
